rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2002-5-10
|
pubmed:abstractText |
To determine the sensitivity and specificity of symptoms, three HIV-1 RNA assays, a p24 antigen EIA and a third-generation enzyme immunoassay (EIA) antibody test for diagnosis of primary HIV infection (PHI).
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1119-29
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12004270-Adult,
pubmed-meshheading:12004270-Cohort Studies,
pubmed-meshheading:12004270-Exanthema,
pubmed-meshheading:12004270-False Positive Reactions,
pubmed-meshheading:12004270-Female,
pubmed-meshheading:12004270-Fever,
pubmed-meshheading:12004270-HIV Antibodies,
pubmed-meshheading:12004270-HIV Core Protein p24,
pubmed-meshheading:12004270-HIV Infections,
pubmed-meshheading:12004270-HIV Seropositivity,
pubmed-meshheading:12004270-HIV-1,
pubmed-meshheading:12004270-Humans,
pubmed-meshheading:12004270-Immunoenzyme Techniques,
pubmed-meshheading:12004270-Male,
pubmed-meshheading:12004270-Middle Aged,
pubmed-meshheading:12004270-Predictive Value of Tests,
pubmed-meshheading:12004270-Prospective Studies,
pubmed-meshheading:12004270-RNA, Viral,
pubmed-meshheading:12004270-Sensitivity and Specificity
|
pubmed:year |
2002
|
pubmed:articleTitle |
Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
|
pubmed:affiliation |
Positive Health Program HIV Section at San Francisco General Hospital, tUniversity of California at San Francisco, 94110, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Evaluation Studies
|